Bill Maughan's Stock Ratings

Canaccord Genuity Analyst

Bill Maughan is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/25/2025

Overall Average Return

-44.2%

Smart Score

19.3%

Overall Average Return Percentile

4th

Number of Ratings

14
Buy NowGet Alert
08/13/2024YMABBuy Now
Y-mAbs Therapeutics
$4.10534.15%
Bill Maughan19%
$26 → $26MaintainsBuyGet Alert
05/10/2024NKTXBuy Now
Nkarta
$2.11610.9%
Bill Maughan19%
$16 → $15MaintainsBuyGet Alert
05/10/2024FATEBuy Now
Fate Therapeutics
$1.28603.13%
Bill Maughan19%
$11 → $9MaintainsBuyGet Alert
05/09/2024IMCRBuy Now
Immunocore Hldgs
$30.16122.15%
Bill Maughan19%
$63 → $67MaintainsHoldGet Alert
05/03/2024MRNABuy Now
Moderna
$27.30288.28%
Bill Maughan19%
$91 → $106MaintainsHoldGet Alert
03/26/2024NKTXBuy Now
Nkarta
$2.11658.29%
Bill Maughan19%
$15 → $16MaintainsBuyGet Alert
03/15/2024IPSCBuy Now
Century Therapeutics
$0.534456.67%
Bill Maughan19%
$22 → $24MaintainsBuyGet Alert
03/04/2024YMABBuy Now
Y-mAbs Therapeutics
$4.10534.15%
Bill Maughan19%
$22 → $26MaintainsBuyGet Alert
02/29/2024IMCRBuy Now
Immunocore Hldgs
$30.16108.89%
Bill Maughan19%
$60 → $63MaintainsHoldGet Alert
02/23/2024MRNABuy Now
Moderna
$27.30233.33%
Bill Maughan19%
$82 → $91MaintainsHoldGet Alert
02/21/2024BCYCBuy Now
Bicycle Therapeutics
$8.42612.59%
Bill Maughan19%
→ $60ReiteratesBuy → BuyGet Alert
11/29/2023MRNABuy Now
Moderna
$27.30200.37%
Bill Maughan19%
→ $82Initiates → HoldGet Alert
11/02/2023MRUSBuy Now
Merus
$43.573.28%
Bill Maughan19%
→ $45Initiates → BuyGet Alert
07/17/2023IMCRBuy Now
Immunocore Hldgs
$30.16122.15%
Bill Maughan19%
→ $67Initiates → HoldGet Alert